论文部分内容阅读
目的:对不同给药方式的盐酸氨溴索在儿科呼吸疾病中治疗效果进行研究。方法:以2013年1月至2014年11月来我院进行治疗的80例呼吸道疾病患儿为研究对象,将其随机分为观察组和对照组(n=40),均给予两组患儿常规治疗,观察组给与雾化吸入治疗,对照组给与静脉注射治疗,对两组患儿的临床疗效、吸痰次数、临床症状改善时间和氧疗时间及住院时间进行比较。结果:观察组和对照组两组患儿的总有效率分别为90.0%和65.0%,治疗组的总有效率比对照组高,差异具有统计学意义(P<0.05);观察组患儿的吸痰次数比对照组少,临床症状改善时间、氧疗时间和住院时间短于对照组患儿,差异具有统计学意义(P<0.05)。结论:盐酸氨溴索在治疗儿科呼吸道疾病方面,其雾化吸入的治疗效果优于静脉注射,有利于减少患儿的吸痰次数,缩短患儿的氧疗时间,改善患儿临床症状和提高患儿的治疗效果,值得临床推广应用。
OBJECTIVE: To study the effect of different administrations of ambroxol hydrochloride in pediatric respiratory diseases. Methods: From January 2013 to November 2014 in our hospital for treatment of 80 cases of respiratory disease in children as the research object, they were randomly divided into observation group and control group (n = 40), were given two groups of children The patients in the observation group were treated with inhalation of atomization and the control group were treated with intravenous injection. The clinical efficacy, the number of sputum aspirates, the improvement of clinical symptoms, the oxygen therapy time and the hospital stay were compared between the two groups. Results: The total effective rates of the two groups were 90.0% and 65.0%, respectively. The total effective rate in the treatment group was higher than that in the control group (P <0.05). The total effective rate in the observation group and the control group was significantly higher than that of the control group The number of sputum aspiration was less than that of the control group, and the clinical symptoms improvement time, oxygen therapy time and hospitalization time were shorter than those in the control group, the difference was statistically significant (P <0.05). Conclusion: Ambroxol hydrochloride is superior to intravenous injection in the treatment of pediatric respiratory diseases, which is beneficial to reduce the frequency of sputum aspiration, shorten the oxygen therapy time and improve the clinical symptoms and improve The therapeutic effect of children, it is worth clinical promotion and application.